Filing Details
- Accession Number:
- 0001209191-22-060128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-06 20:31:29
- Reporting Period:
- 2022-12-02
- Accepted Time:
- 2022-12-06 20:31:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1620463 | Athira Pharma Inc. | ATHA | Biological Products, (No Disgnostic Substances) (2836) | 453368487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1722055 | A Kelly Romano | C/O Athira Pharma, Inc. 18706 North Creek Parkway, Suite 104 Bothell WA 98011 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-02 | 30,000 | $3.29 | 38,315 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
Billionaire Hedge Funds
